1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Virion Therapeutics, LLC

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Newark DE US

Primary Industry

Biotechnology

About

Founded in 2018 and based in Delaware, US, Virion Therapeutics, LLC operates as a biotechnology company that develops immune-based treatments for virally-associated cancers and chronic viral infections. The firm provides vaccines, including ChiVax and ChiVax-gD that represent novel platforms to induce T cell-mediated immune responses against transformed or infected cells.
Current Investors
Keiretsu Forum, Alliance of Angels, Life Science Angels, Inc.

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.viriontx.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo